(Q45754574)

15 December 2017

title

CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus (English)

1 reference

15 December 2017

0 references

Moldoveanu Z

1

1 reference

15 December 2017

Love-Homan L

series ordinal

2

1 reference

15 December 2017

Huang WQ

series ordinal

3

1 reference

15 December 2017

Krieg AM

series ordinal

4

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 July 1998

1 reference

15 December 2017

published in

Vaccine

1 reference

15 December 2017

volume

16

1 reference

15 December 2017

issue

11-12

1 reference

15 December 2017

page(s)

1216-1224

1 reference

15 December 2017

Adjuvants--a classification and review of their modes of action

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980122-9

7 January 2021

Current options for vaccine delivery systems by mucosal routes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980122-9

7 January 2021

CpG motifs in bacterial DNA trigger direct B-cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980122-9

7 January 2021

CpG-rich islands and the function of DNA methylation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980122-9

7 January 2021

Bacterial DNA-induced NK cell IFN-gamma production is dependent on macrophage secretion of IL-12

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980122-9

7 January 2021

Bacterial DNA induces murine interferon-gamma production by stimulation of interleukin-12 and tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980122-9

7 January 2021

DNA from bacteria, but not from vertebrates, induces interferons, activates natural killer cells and inhibits tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980122-9

7 January 2021

CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980122-9

7 January 2021

An innate immune defense mechanism based on the recognition of CpG motifs in microbial DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980122-9

7 January 2021

Amplification of antibody production by phosphorothioate oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980122-9

7 January 2021

Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980122-9

7 January 2021

CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980122-9

7 January 2021

Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980122-9

7 January 2021

CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980122-9

7 January 2021

Oral immunization with influenza virus in biodegradable microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980122-9

7 January 2021

The common mucosal immune system and current strategies for induction of immune responses in external secretions

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980122-9

7 January 2021

The mucosal immune system: from fundamental concepts to vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980122-9

7 January 2021

Oral but not parenteral interleukin (IL)-12 redirects T helper 2 (Th2)-type responses to an oral vaccine without altering mucosal IgA responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980122-9

7 January 2021

Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980122-9

7 January 2021

Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the Cholera toxin B subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980122-9

7 January 2021

Immunogenicity of recombinant adenovirus-human immunodeficiency virus vaccines in chimpanzees following intranasal administration

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980122-9

7 January 2021

Mucosal immune response to an HIV C4/V3 peptide following nasal or intestinal immunization of rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980122-9

7 January 2021

Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucleotides.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980122-9

7 January 2021

Uptake of Oligodeoxyribonucleotides by Lymphoid Cells Is Heterogeneous and Inducible

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980122-9

7 January 2021

Activation of human B cells by phosphorothioate oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980122-9

7 January 2021

10.1016/S0264-410X(98)80122-9

Identifiers

DOI

1 reference

15 December 2017

1 reference

15 December 2017